Literature DB >> 24664185

Intra-articular zoledronic acid in a rat osteoarthritis model: significant reduced synovitis may indicate chondroprotective effect.

B Murat Cınar1, Gurkan Ozkoc, Filiz Bolat, Oguz Karaeminogullari, Nurzen Sezgin, Reha N Tandogan.   

Abstract

PURPOSE: The aim of this experimental study was to evaluate the effect of intra-articular application of zoledronic acid (ZA) on joint cartilage and synovial tissue following induction of knee osteoarthritis (OA) in a rat model.
METHODS: An OA model was created by anterior cruciate ligament transection (ACLT) in the right knees of 48 adult Wistar albino rats. The rats were randomized into a study and control groups, each including 24 rats, and 10 μg of ZA was injected in 0.1 ml of sterile saline to 24 animals in the study group on the first day to operation and was repeated weekly until the rats were killed. The same volume of sterile saline was injected with the same schedule to the control group. Eight rats from both the study and control groups were killed, each time, on the 4th day, the 3rd week, and the 6th week after the operation. The groups were compared based on the histological scores of synovitis and cartilage destruction and the evaluation of serum markers.
RESULTS: Histological score indicates progression of synovitis was significantly less in the study group (p = 0.047). There was significant increase in the mean Mankin cartilage damage score in the control group (p = 0.021), while no significant change was found in the study group. When the two groups were compared over time, no statistically significant difference was detected in total histological scores, although there was a 47 % less incidence of cartilage tissue damage in the study group and better cartilage structure and tide mark integrity scores were also detected in the study group (p = 0.017 and p = 0.021, respectively).
CONCLUSION: Intra- articular zoledronic acid may suppress synovial inflammation. Furthermore, Zoledronic Acid does not reduce cartilage degeneration in early osteoarthritis models, but may provide some chondroprotective effect in ACLT- induced knee osteoarthritis model in rats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664185     DOI: 10.1007/s00167-014-2955-z

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  35 in total

Review 1.  The role of the chondrocyte in osteoarthritis.

Authors:  M B Goldring
Journal:  Arthritis Rheum       Date:  2000-09

2.  Analysis of the histologic variation of synovitis in rheumatoid arthritis.

Authors:  M Rooney; D Condell; W Quinlan; L Daly; A Whelan; C Feighery; B Bresnihan
Journal:  Arthritis Rheum       Date:  1988-08

Review 3.  Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate).

Authors:  O Teronen; Y T Konttinen; C Lindqvist; T Salo; T Ingman; A Lauhio; Y Ding; S Santavirta; H Valleala; T Sorsa
Journal:  Calcif Tissue Int       Date:  1997-07       Impact factor: 4.333

4.  Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.

Authors:  Cesar A Migliorati; Mark M Schubert; Douglas E Peterson; Luis Marcelo Seneda
Journal:  Cancer       Date:  2005-07-01       Impact factor: 6.860

5.  Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis.

Authors:  N V Podworny; R A Kandel; R C Renlund; M D Grynpas
Journal:  J Rheumatol       Date:  1999-09       Impact factor: 4.666

6.  Changes in articular cartilage and subchondral bone histomorphometry in osteoarthritic knee joints in humans.

Authors:  Dragica Bobinac; Josip Spanjol; Sanja Zoricic; Ivana Maric
Journal:  Bone       Date:  2003-03       Impact factor: 4.398

7.  The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis.

Authors:  Laura D Carbone; Michael C Nevitt; Kathryn Wildy; Karen D Barrow; Fran Harris; David Felson; Charles Peterfy; Marjolein Visser; Tamara B Harris; Benjamin W E Wang; Stephen B Kritchevsky
Journal:  Arthritis Rheum       Date:  2004-11

8.  Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease.

Authors:  B W Strassle; L Mark; L Leventhal; M J Piesla; X Jian Li; J D Kennedy; S S Glasson; G T Whiteside
Journal:  Osteoarthritis Cartilage       Date:  2010-07-13       Impact factor: 6.576

9.  Role of subchondral bone in the initiation and progression of cartilage damage.

Authors:  E L Radin; R M Rose
Journal:  Clin Orthop Relat Res       Date:  1986-12       Impact factor: 4.176

10.  Analysis of meniscal and chondral lesions accompanying anterior cruciate ligament tears: relationship with age, time from injury, and level of sport.

Authors:  Reha N Tandogan; Omer Taşer; Asim Kayaalp; Emin Taşkiran; Halit Pinar; Bülent Alparslan; Aziz Alturfan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2003-09-20       Impact factor: 4.342

View more
  7 in total

1.  Pirfenidone reduces subchondral bone loss and fibrosis after murine knee cartilage injury.

Authors:  Deva D Chan; Jun Li; Wei Luo; Dan N Predescu; Brian J Cole; Anna Plaas
Journal:  J Orthop Res       Date:  2017-07-21       Impact factor: 3.494

2.  Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial.

Authors:  Maurizio Rossini; Silvano Adami; Elena Fracassi; Ombretta Viapiana; Giovanni Orsolini; Maria Rosaria Povino; Luca Idolazzi; Davide Gatti
Journal:  Rheumatol Int       Date:  2014-08-01       Impact factor: 2.631

3.  Terminal sterilization influences the efficacy of an extracellular matrix-blood composite for treating posttraumatic osteoarthritis in the rat model.

Authors:  Naga Padmini Karamchedu; Braden C Fleming; Benedikt L Proffen; Nicholas J Sant; Gabriela Portilla; Lauren R Parola; Janine Molino; Martha M Murray
Journal:  J Orthop Res       Date:  2021-05-05       Impact factor: 3.494

4.  Zoledronate promotes ECM degradation and apoptosis via Wnt/β-catenin.

Authors:  Jialing Xiao; Yali Li; Gang Cheng; Guochao Xu
Journal:  Open Med (Wars)       Date:  2022-04-18

5.  MiR-210 inhibits NF-κB signaling pathway by targeting DR6 in osteoarthritis.

Authors:  Dawei Zhang; Xiaorui Cao; Jun Li; Guangyue Zhao
Journal:  Sci Rep       Date:  2015-08-05       Impact factor: 4.379

6.  Effect of antiresorptive and anabolic bone therapy on development of osteoarthritis in a posttraumatic rat model of OA.

Authors:  Cedo M Bagi; Edwin Berryman; David E Zakur; Dean Wilkie; Catharine J Andresen
Journal:  Arthritis Res Ther       Date:  2015-11-06       Impact factor: 5.156

Review 7.  Bisphosphonates as disease-modifying drugs in osteoarthritis preclinical studies: a systematic review from 2000 to 2020.

Authors:  Silvia Fernández-Martín; Mónica López-Peña; Fernando Muñoz; María Permuy; Antonio González-Cantalapiedra
Journal:  Arthritis Res Ther       Date:  2021-02-22       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.